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Background: In late 2011, a new Orthobunyavirus of the Simbu serogroup named Schmallenberg virus (SBV) emerged
in continental Europe. The virus is transmitted by hematophagous arthropods, with the Culicoides species as, so far
known, main vectors. Infection with the virus can cause clinical signs in adult ruminants including diarrhea, fever and
reduced milk production. Transplacental infection of the developing fetus can lead to malformations of varying
severity. To assess seroprevalence of SBV in Sweden an indirect enzyme-linked immunosorbent assay (ELISA) was
established in connection with the surveys. Here, we describe the development and evaluation of the indirect ELISA,
based on whole virus as the coating antigen and a monoclonal antibody for the detection of antibodies to SBV in
ruminant sera. The evaluation includes comparison between the in-house ELISA, virus neutralization test and an indirect
commercial ELISA.
Results: The optimal working dilutions of antigens and conjugate were estimated with checkerboard titrations.
Comparative studies, including ROC analyses, were used for the selection of an optimal cut-off (S/P value = sample
value as percentage of positive control value). With an estimated S/P value of 15% the whole virus ELISA showed a
specificity of 100% and a sensitivity of 99.19% compared to virus neutralization test (VNT) and with a good consistency
as shown in reproducibility and variability experiments. Furthermore, the comparison of our whole virus indirect ELISA
to an indirect ELISA with a SBV nucleoprotein antigen, demonstrated a higher sensitivity of our test.
Conclusion: The indirect whole virus ELISA described in this paper is a readily available test for serological analysis of
SBV antibodies. Since this in-house ELISA demonstrates a specificity and sensitivity comparable to virus neutralization
test and also shows a higher sensitivity compared to commercially available indirect ELISA, it is a useful alternative for
surveillance and screening purposes of SBV.
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Since Schmallenberg virus (SBV) was identified in Octo-
ber 2011 [1] cases of SBV infection have been reported
in ruminants in most European countries [2] and, as of
late 2012, also in Sweden [3]. In cattle, clinical signs in-
clude loss of appetite, fever, diarrhea and decreased milk
production [4-6]. In addition, if SBV infection of fetuses
occurs during a vulnerable stage in pregnancy, the SBV
can induce neurological disorders in newborns and may
lead to congenital malformations with intra-uterine or
neonatal death [7-11].
The Schmallenberg virus is a member of the genus
Orthobunyavirus within the family Bunyaviridae and re-
lated to the Simbu serogroup [1]. The virus genome
consists of 3 segments of negative-sense single-stranded
RNA: the L (large), M (medium) and S (small) segments
[12]. The enveloped virus particle has a diameter of ap-
proximately 100 nm [13] and is composed of 4 struc-
tural proteins: two surface glycoproteins, the Gn and
Gc, the polymerase protein (L) and the nucleoprotein
(N). Results of full-genome and serologic investigations
indicate that SBV belongs to the species Sathuperi virus
and is not a reassortant but rather likely one of the an-
cestors of Shamonda virus [14].
In the spring of 2012, before the vector season started,
several serosurveys were performed in Sweden [3]. At
that time, only one commercial indirect ELISA based on
a recombinant SBV nucleocapside protein antigen was
available [15]. It was found that this test sometimes gave
unspecific results according to virus neutralizing test
performed at our laboratory and at Animal Health La-
boratory at ANSES. Also, the virus neutralization test
developed at our laboratory did not have the capacity
for more extensive surveys. Since the surveys were
planned to include both sera and bulk milk it was desir-
able to establish an ELISA potentially useful for both
sera and milk which also was rapid and sensitive enough
for mass screening.
The present study describes the establishment and
evaluation of an indirect ELISA for the detection of anti-
bodies to SBV in cattle, sheep and goat sera.Table 1 Origin of virus neutralization test positive and negat
Origin of sera Bovine
Pos N
France, Animal Health Laboratory at ANSES 29
The Netherlands, Animal Health Service (GD)
Finland, Finnish Food Safety Authory, (EVIRA) 9
Sweden, National Veterinary Institute, (SVA) 23 11





The Schmallenberg virus isolate BH80/11-4, kindly provided
by the Friedrich-Loeffler-Institut, Germany, was used for the
ELISA antigen preparation and in virus neutralization test
(VNT) [1,14]. After an initial propagation in BHK-21
cells, the virus was passaged on Vero cells cultivated in
Eagle’s minimal essential medium (EMEM) complete
(SVA, Sweden) with 2% fetal bovine serum (FBS). A
master seed stock of 104.25 TCID50/ml was prepared, ali-
quoted and stored in −80°C until used.
Serum samples
SBV positive and negative ruminant sera, as confirmed by
virus neutralizing test (VNT), were used for determining
cut-off values, specificity and sensitivity of the in-house
ELISA and for comparative studies between the in-house
ELISA, VNT and a commercial ELISA.
The sera included three hundred negative sera col-
lected from Swedish holdings before any introduction of
SBV to Sweden was confirmed as well as positive sera
from naturally infected animals, including 64 bovine, 48
ovine and 11 caprine sera from France, The Netherlands,
Finland and Sweden (see Table 1).
SBV neutralizing antibody assay
Serum samples were analyzed for neutralizing antibodies
in a virus neutralizing test (VNT) designed for SBV at
our laboratory. The virus isolate used was BH80/11-4,
and passaged in BHK-21 cells cultivated in Eagle’s
minimal essential medium (EMEM) complete (SVA,
Sweden) with 2% FBS. Before analyzing, the sera were
heated for 30 min at 56°C. The VNT was performed in
96-well microtitreplates in which sera were 2-fold di-
luted in EMEM in volumes of 50 μl in duplicate starting
from 1:2 up to 1:256. Between 30 and 300 TCID50 of
virus in a volume of 50 μl per well was then added to
the microtitreplates with the exception of the first row
with 1:2 serum dilutions where only medium was added
(serum controls). After preincubation at 37°C for 1 h ap-
proximately 20000 cells in a volume of 50 μl in EMEMive Schmallenberg virus sera used
Ovine Caprine
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The plates were then incubated for 3–4 days at 37°C
under 5% CO2. After incubation, the plates were exam-
ined in a light microscope for the presence of virus spe-
cific cytopathogenic effects (cpe). The neutralizing titer
of a serum was determined as the highest dilution in
which the cell monolayer was intact. In each run of the
VNT, positive and negative control sera were included.
Commercial indirect ELISA for detection of SBV antibodies
A commercial indirect ELISA based on a recombinant SBV
nucleocapside protein antigen and a multi-species conju-
gate [15] was used for comparative purposes. The analysis
and the interpretation of the results were performed in
accordance to the protocol. The optical density (OD) of a
sample tested (S) was compared with the OD of the posi-
tive control (PC) to give an S/P percentage value (ODsam-
ple)/ODpositive control × 100). A S/P value of >60% was
considered as positive.
Preparation of ELISA antigens
SBV was cultivated in Vero cells for the preparation of
virus antigen. Non infected Vero cells were used for the
preparation of control antigen.
Vero cells were grown at 37°C to 80-90% confluence in
162 cm2 tissue culture bottles (Costar, Corning Inc., USA).
The medium was removed and the cell monolayer was
rinsed with phosphate-buffered saline (PBS) and then in-
oculated with 10 ml of virus diluted 1:10 in EMEM with-
out FBS. After one hour of adsorption at 37°C, 40 ml of
EMEM with 2% FBS was added to the virus infected cells.
The cultures were then incubated at 37°C under daily ob-
servation. When a cytopathogenic effect of 80-90% was
seen, usually after 2 days, the cultures were frozen at −80°
C. Non-infected Vero cells grown and handled under
similar conditions were used for the preparation of control
antigen. The cell bottles were freeze-thawed consecutively
two times and the material was centrifuged at 1500 x g for
15 min. The pelleted cell debris were dissolved in 1/100 of
the starting volume in PBS and stored in −80°C until used.
The supernatants were precipitated and concentrated with
10% polyethylene glycol (PEG) as described by Simard
et al. [16] with minor modifications. Briefly, the superna-
tants were mixed with 30% (w/v) PEG 8000 (Fisher Scien-
tific) in 0.4 M NaCl at a ratio of 2:1 and stirred for 1 h at
4°C. The precipitates were pelleted by centrifugation at
1500 x g for 20 min and thereafter dissolved in 1/100 of
the original volume in PBS, dialyzed against Super Q
water over night and finally against PBS for 4 h with the
use of a dialysis membrane with 12–14 kDalton cut off
(Spectra/Por® 2, VWR). To solubilise and inactivate virus,
the PEG precipitated concentrates of virus and the cell
bound virus of the cell debris fractions were treated by
adding Triton x-100 (Merck) to a final concentration of0.1%, 0.5 and 1% (v/v). The solutions were then sonified in
two cycles of 5 min in an ultrasonic water bath (Bandelin
Sonorex) and incubated with agitation at room temperature
for 15 min between the sonifying steps, clarified by centri-
fugation for 15 min at 1500 × g and then stored in −80°C
until used. The different concentrations of Triton x-100 of
the virus inactivation step were evaluated by three passages
in Vero cells. Before inoculation the Triton x-100 was re-
moved due to its cell toxicity by gel filtration on Sephadex
G-25 GE-Healthcare Uppsala Sweden) in PBS [17].
Optimization of ELISA
Checkerboard titrations were performed to find optimal
working dilutions of antigens and conjugate. Three vari-
ants of virus and control antigens were tested; the antigen
concentrated by PEG saturation (A), antigen from the cell
debris fraction (B) and a combination of PEG precipita-
tedted antigen and cell debris antigen (A + B). Bovine sera
with a VNT titer 1:128 and <1:4 was used as positive and
negative controls. A HRP conjugated monoclonal anti-
body anti-bovine IgG1 also binding to ovine and caprine
IgG (Boehringer Ingelheim Svanova, Sweden) was used as
conjugate. The antigens were initially titrated in two-fold
dilutions from 1:1000 to 8000, and thereafter evaluated in
the dilution range of 1:1500 to 1:4000. The sera were di-
luted 1:100 and the conjugate was diluted 1:5000, 1:10
000, 1:20 000 and 1:40 000.
Western blot analysis
The antigen consisting of the A + B combination were
separated on 10% SDS-PAGE and transferred onto a
0.45 μm nitrocellulose membrane (Bio-Rad) at 100 V for
1 h with a Criterion™ Blotter (Bio-Rad). The membrane
was blocked with 5% skimmed milk powder in Tris-
buffered saline pH 7.6 with 0.05% Tween-20 (TBS-T)
and cut into stripes. The SBV proteins on the blot were
detected by SBV positive sheep and cattle sera. Sera
from uninfected animals were used as controls. All sera
were diluted 1:100 in TBS-T and incubated for 1 h at
room temperature (RT). The stripes were washed with
TBS-T and then incubated with a HRP conjugated
mouse anti-bovine IgG1 (Boehringer Ingelheim Svanova,
Sweden) diluted 1:10 000 in TBS-T. After one hour in-
cubation at RT the strips were washed and the bound
secondary antibodies were detected by using ECL sub-
strate and Hyper film ECL (Amersham/GE Healthcare).
Final ELISA protocol
According to the results from checkerboard titrations of
the different preparations of ELISA reagents the following
basic protocol was implemented:
Microtitreplates (Polysorp; Nunc, Denmark) where
coated with virus antigen and control antigen diluted
1:3000 in 0.05 M carbonate buffer, pH 9.6 and incubated
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0.01 M PBS, pH 7.4 containing 0.05% Tween-20 (PBST).
Serum samples diluted 1:100 in PBST with 3% FBS were
added in an antigen and a control antigen coated well.
After incubation for one hour at 37°C the plates were
washed three times with PBST and the conjugate at a 1:20
000 dilution in PBST was added. The plates were then in-
cubated for one hour at 37°C. After washing four times in
PBST a TMB (3, 3’, 5, 5’-tetramethylbenzidine) substrate
solution was added and incubated for 10 min at room
temperature thereafter the reaction was stopped by adding
2 M H2SO4. The optical density (OD) was measured at
450 nm with a Multiskan EX microplate photometer
(Thermo Labsystems). Positive, low positive and negative
control sera were included on each plate for the evaluation
of each assay. The OD value of each sample and control
sera was calculated as the difference between the OD
values of the virus antigen well and the control antigen
well (net OD values). The results of the serum samples
were then expressed as percentage of the positive control
serum (S/P%).
Determining the cut-off values and calculation of
sensitivity and specificity
Three hundred VNT negative and 123 positive cattle, sheep
and goat sera (see Table 1) were analyzed in a two-graph
receiver operating characteristic (TG-ROC) curve to deter-
mine the optimal cut-off value and to calculate the sensitiv-
ity and the specificity.
Inter and intra-assay variation
Four positive bovine sera were tested in 12 replicates to
evaluate the inter- and intra-assay variation of the in-house
ELISA. The sera were tested on five different occasions and
the coefficient of variation (CV) was calculated between
plates for the inter-assay variation (reproducibility) and
within the plates for the intra-assay variation (variability).
Comparison between in-house ELISA, VNT and a
commercial ELISA
The relative specificity and sensitivity of the in-house
ELISA and a commercial ELISA [15] were compared to
VNT with the use of 112 positive and 200 negative cattleTable 2 Relative specificity and sensitivity of in-house Schma
compared to virus neutralization test (VNT)
VNT In-house SBV ELISA
Cattle Sheep
Pos Neg Pos Neg
Pos 64 47 1
Neg 100 100
Specificity 100% (100/100) 100% (100/100)
Sensitivity 100% (64/64) 97.9% (47/48)and sheep sera (see Table 2). In addition, four positive bo-
vine sera were used undiluted and serially two-fold diluted
for comparison of sensitivity between the in-house ELISA
and the commercial ELISA versus VNT (Table 3).
Data analysis
MedCalc® v2.3.0 software was used for the TG-ROC ana-
lysis and dot plot graph.
Results
Antigen preparation and optimization of the in-house
ELISA
After cultivating SBV on Vero cells the cultures were
freeze-thawed and then centrifuged to separate the cell
debris from the cultivating material. Virus in the super-
natant was concentrated by PEG precipitation. Both the
pelleted cell debris fraction and the PEG concentrated
virus were then treated with Triton x-100 at three differ-
ent concentrations of 0.1%, 0.5%, 1.0%, to explore the
concentration required for an optimal solubilization and
virus inactivation. The preparations were inoculated on
to Vero cells to detect any presence of infectious virus
by its CPE. Virus prevalence was found already at the
first passage when a concentration of 0.1% of Triton x-
100 was used. At a Triton x-100 concentration of 0.5%
virus could be demonstrated after 2 passages on cell cul-
tures. When a Triton x-100 concentration of 1.0% was
used no virus could be detected even after three pas-
sages on cell cultures.
The virus content of the cell debris fraction and the
PEG concentrated virus was preliminary evaluated in an
ELISA by serially dilutions. Both fractions were treated
with 1.0% Triton x-100, in addition the cell debris frac-
tion was centrifuged to remove residual cell debris, be-
fore the evaluation. Since it was found that the amount
of cell bound virus was significant, three different prepa-
rations were finally evaluated, one from the PEG con-
centrated virus (A), one from the original cell debris (B)
and a combination of both (A + B).
Checkerboard titrations were performed to select the
optimal dilution and preparation of the three different
antigen variants and the optimal dilution of conjugate.
Figure 1, shows the ratio between the positive andllenberg virus (SBV) ELISA and a commercial SBV ELISA
Commercial SBV ELISA
Cattle Sheep
Pos Neg Pos Neg
59 5 39 9
100 100
100% (100/100) 100% (100/100)
92.2% (59/64) 81.2% (39/48)
Table 3 Comparison of sensitivity of the in-house Schmallenberg virus ELISA (A) and a commercial SBV ELISA (B) versus




611 612 615 616
VNT A B VNT A B VNT A B VNT A B
1:1 1:32 98 96 1:64 76 189 1:64 95 120 1:64 81 64
1:4 1:16 34 53 1:16 34 213 1:32 49 102 1:16 36 25
1:8 1:8 18 34 1:8 22 132 1:16 31 61 1:8 24 21
1:16 1:4 9 17 1:4 15 86 1:4 16 35 <1:4 11 11
1:32 <1:4 3 8 <1:4 8 43 <1:4 7 16 1:4 6 −4
1:64 <1:4 3 4 <1:4 4 23 <1:4 5 9 <1:4 3 11
Four out of the positive sera from France (see Table 1); serially diluted 1:4 to 1:64 in negative serum were analyzed in accordance with the protocol of each test.
The sera and sera dilutions where further diluted 1:100 in ELISA A, 1:10 in ELISA B and serially diluted 1:4 to 1:256 in VNT. Bold-figures indicate positive results,
under-lined figures doubtful results. Thresholds: VNT titer ≥1:8 = positive. ELISA A; S/P% ≥15 = positive, ELISA B; S/P ≥50-60 = doubtful, >60 = positive.
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positive serum against the different antigen dilutions. A
maximum P/N value for all three antigen preparations
was obtained with an antigen dilution of 1:2000. From
the comparative checkerboard titrations only a slight dif-
ference in P/N values between the PEG concentrated
virus (A) and the combined antigen (A + B), could be
found. By using the combined antigen A + B, the antigen
recovery was increased with approximately 75%. Further
titrations of the combined antigen preparation were car-
ried out and an antigen dilution of 1:3000 and a conju-






































Figure 1 Serially dilutions of three variants of Schmallenberg
virus ELISA antigen. A: PEG precipitated antigen, B: cell debris
derived antigen and A + B: a combination of A and B tested with
positive and negative sera diluted 1:100 and conjugate diluted 1:20
000. Bars shows optical density (OD) for positive serum, lines shows
ratio between positive and negative sera (P/N value).lowest background while maintaining a maximum P/N
value. Western blot analysis of the ELISA antigen with
the use of sera from SBV naturally infected and non in-
fected cattle and sheep revealed the presence of both
nucleocapside protein (N) and the glycoprotein Gc
(Figure 2).
The reproducibility of the antigen preparation method
was confirmed by the comparison of three separately
manufactured batches (data not shown).Determining the cut-off values and the relative sensitivity
and specificity
To determine the cut-off value and to calculate the rela-
tive sensitivity and specificity a TG-ROC analysis was
performed with the use of all VNT positive and VNT
negative sera (see Table 1). It was found that a S/P value
ranging from 8 to 15% gave a sensitivity of 99.19% and a
specificity of 100% (Figure 3). The distribution of the S/
P values of each group is shown in Figure 4. The cut-off
value was further validated by comparing the analysis re-
sults of the in-house ELISA and VNT by using serially
diluted bovine sera in a negative serum (see Table 3). An
overall evaluation of the results of this comparison and
the results of the TG-ROC analyses above resulted in
the selection of a cut-off value of S/P 15%.Reproducibility and variability of the ELISA
The reproducibility of the ELISA was tested by analyzing
four different sera with S/P values ranging from 35 to 160
in an inter variation assay, on five different occasions. The
mean results of the four sera tested in duplicates, gave a
coefficient of variation (CV) of 5.0%. Analysis of the intra
plate variation, including 12 replicates of the four sera on
one plate, gave a mean CV of 4.5%. These data suggest
that the in-house ELISA has the capacity to generate re-
producible results with low variation.
Figure 3 TG-ROC curve. The curves show the sensitivity and
specificity relative to VNT at different cut-off values (S/P%) of the
in-house ELISA. All of three hundred VNT negative and 123 positive
bovine, caprine and ovine sera (see Table 1) were used for analysis.
Within the range of S/P 8% to 15% the analysis gives a sensitivity of
99.19% and a specificity of 100%.
Figure 4 The dot plot graph illustrates the distribution of ELISA
S/P% values relative to virus neutralizing test (VNT) antibody
titers. Three hundred VNT negative and 125 VNT positive bovine,
caprine and ovine sera (see Table 1) were included in the analysis.
The S/P values of the negative bovine sera varied from −1 to 6 and
the positive sera from 37 to 162. The S/P values of the negative
caprine sera varied from −2 to 5 and the positive sera from 32 to
118. The S/P values of negative ovine sera ranged from −2 to 8 and
the positive sera from 16 to 131. One VNT positive ovine sera got an
S/P value of 0.












Figure 2 Identification of nucleoprotein (N) and glycoprotein
(Gc) of the in-house ELISA antigen. Western blot analysis of the
final ELISA antigen (A + B) was performed using sera from naturally
SBV infected sheep (lane 1) and cattle (lane 3). Sera from uninfected
sheep and cattle were used as controls (lane 2 and 4).
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in-house ELISA, VNT and a commercial ELISA
Table 2 shows the results of two-sided contingency com-
parison between the two ELISAs versus VNT in the ana-
lysis of bovine and ovine sera. Also, comparative analyses
of 11 VNT positive and 100 negative caprine sera revealed
a specificity of 100% for both ELISAs but higher sensitivity
of the in-house ELISA compared to the commercial
ELISA (11 positive compared to 9 positive, 1 doubtful and
1 negative). To compare the limits of detection between
the in-house ELISA, the commercial ELISA and the VNT
four serially diluted positive bovine sera were analyzed
(see Table 3). The results showed a higher or equal sensi-
tivity of the in-house ELISA compared to VNT. In com-
parison with the commercial ELISA, the in-house ELISAshowed substantially higher sensitivity at analyzing two
out of the four serially diluted sera (see Table 3, sera num-
bers 611 and 616). Analysis of the remaining two sera
showed comparable sensitivity between the in-house
ELISA and the commercial ELISA.
Discussion
The SBV is now established throughout Europe. The use
of serological surveys makes large scale testing possible
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ease transmission dynamics. For serosurveillance and
seromonitoring purposes in Sweden, an indirect ELISA
was developed using whole SBV as antigen. In this work,
we present the development and the evaluation of an in-
direct in-house ELISA to detect antibodies from cattle,
sheep and goat against the full SB virus. Evaluation of
the in-house ELISA was done by comparing results with
VNT and a commercial ELISA based on a recombinant
SBV nucleoprotein.
During the preparation of the ELISA SBV antigen from
infected cell cultures it was found that the obtained cell
material fraction contained considerable amount of viral
proteins. This has previously been reported for virus be-
longing to the Simbu serogroup [18,19]. By utilizing the
cell associated virus in combination with the non-cell-
bound virus the antigen recovery was increased consid-
erably with about 75%.
Triton x-100 was used for virus inactivation. This solv-
ent/detergent works by disrupting the lipid layer of envel-
oped viruses. The method is effective, simple and rapid
with a confirmed capacity to inactivate model enveloped
viruses by >4 to >6 log after 30 min at 22°C [20,21]. The
required amount of Triton x-100 for virus inactivation of
SBV as confirmed after three passages on cell cultures was
found to be 1.0% which is in compliance with previously
reported experiments [21].
In assessing the cut-off value of the in-house ELISA,
not only high sensitivity with a maximized specificity
was taken into account, but also the varying distribution
of the S/P values and the degree of separation between
positive and negative sera of each group of cattle, sheep
and goat sera. Based on TG-ROC analysis of positive and
negative sera as well as comparative analysis of in-house
ELISA and VNT of serially diluted bovine sera in negative
bovine serum, the cut-off value of S/P =15 was finally
selected giving an overall sensitivity of 99.19% and a speci-
ficity of 100%. The prevalence of both nucleocapside pro-
tein (N) and the glycoprotein (Gc) of the ELISA antigen
were confirmed by western blot analysis. Along with the
glycoprotein Gn, the Gc glycoprotein is involved in viral
attachment and cell fusion and is considered to be the tar-
get for neutralizing antibodies [22-24]. The presence of
both nucleocapside protein and Gc glycoprotein in the
ELISA antigen may thus explain the similar sensitivity
compared to VNT. Also, the broader spectrum of anti-
genic regions of the ELISA antigen may contribute to the
higher sensitivity compared to a commercial ELISA which
use a nucleocapside recombinant protein as antigen. The
high performance of the in-house ELISA reported in this
work was confirmed in a limited interlaboratory compari-
son of SBV antibody detection [25].
The conjugate, a monoclonal antibody against bovine
IgG1, is developed and evaluated to detect cattle, sheepand goat antibodies in sera. Since IgG1 represent the
major Ig class in milk throughout the lactation period,
this conjugate was thought to be particularly useful in
the detection of milk antibodies [26,27]. Further devel-
opment and evaluation to optimize this in-house ELISA
for analyzing bulk milk is in progress.
Conclusion
An indirect ELISA was established with the use of whole
virus as coating antigen and a monoclonal antibody for
the detection of antibodies to SBV in bovine, ovine and
caprine sera. The in-house ELISA showed good reprodu-
cibility and repeatability with high correlation to virus
neutralization test. In a comparative study between the in-
house ELISA, based on whole virus, and an ELISA based
on recombinant nucleoprotein, the former showed a
higher sensitivity indicating that the use of whole virus as
antigen in this case, can be of advantage. The assay pro-
vides a rapid serological detection method that would be
suitable for serosurveillance of SBV infection on a large
scale.
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